OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

By afschroeder • March 20, 2026

Alhelaly M, Soylu C, Oncel D, Corradetti G, Chen K, Jackson NJ, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath AV, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Sadda SR, Madow B, Coyne AB, Acharya NR, Tsui E. OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. Ophthalmol Sci. 2026 Feb 5;6(4):101106. doi: 10.1016/j.xops.2026.101106. PMID: 41853570; PMCID: PMC12995472.

Tags: DOM STAT, FAST, General Internal Medicine, OCT-based vitreous signal intensity, Publications, Standardization of Uveitis nomenclature, uveitis, Vitreous haze

The Journey of the “Asthmanaut”: Communicating Dyspnea Through Poetry

Tsevat RK, Campo R. The Journey of the "Asthmanaut": Communicating Dyspnea Through Poetry. JAMA. 2026 Mar 25. doi: 10.1001/jama.2026.1511. Epub ahead of print. PMID: 41879768.

Minimal Clinically Important Difference of the Sinonasal Outcome Test in Sinonasal Malignancy

Maoz SL, Lee M, Fischer JL, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Pinheiro-Neto[...]

An enigmatic rash: When the obvious isn’t

Ragaisis T, Kingsley T. An enigmatic rash: When the obvious isn't. JAAPA. 2026 Apr 1;39(4):45-47. doi: 10.1097/01.JAA.0000000000000333. Epub 2026 Mar 24. PMID: 41874093.